摘要
目的探讨经尿道电切术同期治疗膀胱肿瘤合并良性前列腺增生的效果。方法选取2015年1月—2018年12月的100例膀胱肿瘤合并良性前列腺增生患者,随机分为两组。对照组行经尿道膀胱肿瘤电切术,研究组同期行经尿道电切术,观察两组的相关手术指标,治疗前后国际前列腺症状评分(IPSS)评分、残余尿量(Postvoid residual,PVR)、最大尿流率(Maximum urinary flow rate,Qmax)、健康SF-36量表(中文版)评分。结果研究组术中出血量为(62.50±5.30)mL,少于对照组(114.55±6.35)mL(t=36.150,P<0.05);研究组手术时间为(72.55±12.65)min,膀胱冲洗时间为(2.65±0.05)d,留置导管时间为(2.60±1.01)d,卧床时间为(3.50±1.50)d,住院时间为(6.05±2.10)d,短于对照组(t=16.760、7.740、9.830、5.890、6.900,P<0.05);研究组治疗后IPSS评分为(10.50±2.20)分,低于对照组(t=14.510,P<0.05);研究组治疗后PRV为(13.15±9.05)mL,低于对照组(t=7.130,P<0.05);研究组治疗后Qmax为(15.20±1.30)mL/s,高于对照组(t=16.640,P<0.05);研究组治疗后总体健康为(74.65±12.40)分,生理功能为(72.75±13.90)分,生理职能为(65.65±10.75)分,躯体疼痛为(69.85±11.40)分,活力为(80.70±14.60)分,社会功能为(81.50±14.40)分,情感职能为(90.30±12.80)分,精神健康为(76.80±13.50)分,高于对照组(t=4.500、2.030、3.000、2.250、2.690、2.060、4.000、3.390,P<0.05)。结论经尿道电切术同期治疗膀胱肿瘤合并良性前列腺增生的效果显著。
Objective To investigate the effect of transurethral resection of bladder tumor with benign prostatic hyperplasia.Methods One hundred patients with bladder tumor complicated with benign prostatic hyperplasia from January 2015 to December 2018 were randomly divided into two groups.The control group underwent transurethral resection of the bladder tumor.The study group underwent transurethral resection of the urethra.The relevant surgical indexes were observed.The international prostate symptom score(IPSS)score,residual void volume(PVR),maximum urine before and after treatment.Maximum urinary flow rate(Qmax)and healthy SF-36 scale(Chinese version)score.Results The intraoperative blood loss was(62.50±5.30)m L,which was less than that of the control group(114.55±6.35)mL(t=36.150,P<0.05).The operation time of the study group was(72.55±12.65)min,and the bladder irrigation time was(2.65±0.05)d,indwelling catheter time was(2.60±1.01)d,bedtime was(3.50±1.50)d,hospital stay was(6.05±2.10)d,shorter than control group(t=16.760,7.740,9.830,5.890,6.900,P<0.05);the IPSS score of the study group was(10.50±2.20)points,which was lower than that of the control group(t=14.510,P<0.05).The PRV of the study group was(13.15±9.05)mL after treatment,which was lower than the control group(t=7.130,P<0.05);the Qmax of the study group was(15.20±1.30)mL/s,which was higher than that of the control group(t=16.640,P<0.05).The overall health of the study group after treatment was(74.65±12.40)points,the physiological function was(72.75±13.90)points,the physiological function was(65.65±10.75)points,the physical pain was(69.85±11.40)points,the vitality was(80.70±14.60)points,and the social function was(81.50±14.40)points,emotional function was(90.30±12.80)points,mental health was(76.80±13.50)points,higher than the control group(t=4.500,2.030,3.000,2.250,2.690,2.060,4.000,3.390,P<0.05).Conclusion Transurethral resection is effective in the treatment of bladder tumor with benign prostatic hyperplasia.
作者
徐洪磊
XU Hong-lei(Department of General Surgery,Wucheng County People's Hospital,Dezhou,Shandong Province,253300 China)
出处
《世界复合医学》
2020年第1期58-60,共3页
World Journal of Complex Medicine
关键词
经尿道电切术
同期治疗
膀胱肿瘤
良性前列腺增生
Transurethral resection
Concurrent treatment
Bladder tumor
Benign prostatic hyperplasia
